5-AMINO-1-(2-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE, 95.0%, 1g

5-Fluoro-3-(methylthio)benzyl alcohol, 95%, 1g

N,N-Diéthylaniline , >=98.5%, pour la synthèse, 250 ml, emballage en verre

6-hydrazinoimidazo[1,2-b]pyridazine, 95.0%, 250mg

Methyl Chromane-2-carboxylate, 97.0%, 5g

(E)-5-(2-Bromovinyl)-2'-deoxyuridine>98.0%(HPLC)(T)100mg

2-Phenoxy-1-piperazin-1-yl-ethanone xhydrochloride, 95.0%, 10g

4-Methyl-3-propoxy-1H-1,2,4-triazol-5(4H)-one, 95.0%, 100mg

2-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine, 95.0%, 5g

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-3H-purin-2-yl)isobutyramide, 97%, 100mg

4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridine hydrochloride, 95.0%, 1g

9-((1R,4S)-4-(tert-Butoxymethyl)cyclopent-2-en-1-yl)-N6-cyclopropyl-9H-purine-2,6-diamine, 98.0%, 1g

6-(tert-butyl)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 500mg